Abbonarsi

Association of glycated hemoglobin with the risk of advanced fibrosis in non-alcoholic fatty liver disease patients without diabetes - 07/02/19

Doi : 10.1016/j.clinre.2018.08.007 
Chao Yu a, b, , 1 , Liqing Wang c, 1, Hongliang Xue b, Hongmei Lin a, Yanping Li b, Sun-On Chan d
a Center for Health Examination, The 3rd Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong Province, PR China 
b Department of Nutrition, School of Public Health, Sun Yat-sen University, Guangdong, PR China 
c Department of Neurology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, PR China 
d School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, PR China 

Corresponding author at: Center for Health Examination, The 3rd Affiliated Hospital, Sun Yat-sen University, 600 Tianhe Road, Guangzhou, Guangdong Province, PR China.Center for Health ExaminationThe 3rd Affiliated HospitalSun Yat-sen University600 Tianhe RoadGuangzhouGuangdong ProvincePR China

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

pagine 9
Iconografia 3
Video 0
Altro 0

Highlights

HbA1c levels within normal range are independently associated with the presence of non-alcoholic fatty liver disease (NAFLD) in non-diabetics, in a dose-response manner.
High HbA1c levels are associated with increased risks of advanced fibrosis in NAFLD patients without diabetes, independent of potential confounders.
HbA1c may be a novel biomarker for the management of NAFLD patients with or without diabetes.
A proactive approach in assessment of HbA1c should be routinely performed in the management of patients with NAFLD.

Il testo completo di questo articolo è disponibile in PDF.

Summary

Background

Association of diabetes with non-alcoholic steatohepatitis has been well documented. However, it remains unclear whether there is an association between levels of glycated hemoglobin (HbA1c) with severity of non-alcoholic fatty liver disease (NAFLD). This study was aimed to explore the relationship between levels of HbA1c and the risk of advanced fibrosis in patients with NAFLD.

Methods

A cross-sectional study was performed on 4826 apparently healthy Chinese, who underwent a health check between January 2015 and December 2016. NAFLD was defined as hepatic steatosis on ultrasonography in the absence of excessive alcohol use or other identifiable causes. The risk of advanced fibrosis was assessed by NAFLD fibrosis Score.

Results

Among 4826 individuals studied, 1630 were diagnosed with NAFLD. In a multivariable-adjusted model, high HbA1c levels were associated independently with increased prevalence of NAFLD. The adjusted odds ratio [95% confidence interval (95% CI)] for NAFLD, when compared with the highest HbA1c quartile and the lowest HbA1c quartile, was 2.72 (2.07–3.58; P for trend < 0.001). A strong association was also observed between HbA1c level and the risk of fibrosis in patients with NAFLD in multivariable analyses, with the extreme-quartile odds ratio of 2.69 (95% CI: 1.60–4.53; P for trend < 0.001). This association remained significant even in subjects without diabetes.

Conclusions

We concluded that high HbA1c level was associated strongly and independently with increased risk of advanced fibrosis in NAFLD patients without diabetes.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Advanced fibrosis, Glycated hemoglobin A1c, Non-alcoholic fatty liver disease, Obesity


Mappa


© 2018  Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 43 - N° 1

P. 58-66 - Febbraio 2019 Ritorno al numero
Articolo precedente Articolo precedente
  • Role of vitamin D deficiency as a risk factor for infections in cirrhotic patients
  • Haidi K. Ramadan, Nahed A. Makhlouf, Amal A. Mahmoud, Mohamed Abd Elrhman, Muhammad Abbas El-Masry
| Articolo seguente Articolo seguente
  • Elevated lactate impairs the efficacy of antiviral treatment on post-hepatectomy survival for advanced stage hepatitis B virus?–?related hepatocellular carcinoma
  • Jianping Zhao, Jingjing Wang, Songshan Chai, Yuxin Zhang, Wanguang Zhang

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.